Regimens Comparison for Breast Cancers of Positive Lymph Nodes
To compare the efficacy and safety of EC-T and ET regimen as adjuvant treatment of breast cancer patients with positive lymph nodes
Breast Cancer
DRUG: Epirubicin, CTX, Paclitaxel|DRUG: Epirubicin, Paclitaxel
PFS, 5 years after all the recuiment
OS, 5 years after all the adjuvent treatments|Safety, Assessing for Hematology and Non-hematology toxicities, including all SAEs., 5 years after all the recruiment
EC-T regimen: epirubicin 90mg/m2 day1, CTX 600mg/m2, day 1, 21 days per cycle \*4cycle. followed by paclitaxel 175mg/m2,d1,21days per cycle, 4 cycle.

ET regimen: epirubicin 75mg/m2 day1,paclitaxel 175mg/m2,d2,21days per cycle, 6 cycle